Loading company…
Protembis GmbH, based in Aachen, develops the ProtEmbo Cerebral Protection System to reduce brain injury during TAVR procedures.
Founded in 2013 and based in Aachen, Germany, Protembis GmbH develops brain protection technology for cardiology procedures, especially transcatheter aortic valve replacement (TAVR). Its ProtEmbo Cerebral Protection System is used during TAVR to reduce silent brain infarcts, and it is sold to hospitals in Europe and North America. The company's latest Series B round, raising EUR 30.000 mn, was led by 5FP GbR and ARVE Capital. Conrad Rasmus is the founder.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in